Solid Biosciences (SLDB) Assets (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.86% |
| Dec 31, 2025 | -15.10% |
| Sep 30, 2025 | -11.15% |
| Jun 30, 2025 | -10.36% |
| Mar 31, 2025 | 82.29% |
| Dec 31, 2024 | -10.94% |
| Sep 30, 2024 | -8.29% |
| Jun 30, 2024 | -7.12% |
| Mar 31, 2024 | 50.78% |
| Dec 31, 2023 | -10.71% |
| Sep 30, 2023 | -9.77% |
| Jun 30, 2023 | -10.83% |
| Mar 31, 2023 | -11.78% |
| Dec 31, 2022 | 41.08% |
| Sep 30, 2022 | -11.52% |
| Jun 30, 2022 | 0.45% |
| Mar 31, 2022 | -10.68% |
| Dec 31, 2021 | -6.67% |
| Sep 30, 2021 | -6.35% |
| Jun 30, 2021 | -6.81% |
| Mar 31, 2021 | 66.67% |
| Dec 31, 2020 | 322.45% |
| Sep 30, 2020 | -30.10% |
| Jun 30, 2020 | -21.63% |
| Mar 31, 2020 | -28.52% |
| Dec 31, 2019 | -20.97% |
| Sep 30, 2019 | 35.95% |
| Jun 30, 2019 | -19.90% |
| Mar 31, 2019 | -13.87% |
| Dec 31, 2018 | -10.98% |
| Sep 30, 2018 | -8.55% |
| Jun 30, 2018 | -9.39% |
| Mar 31, 2018 | 148.37% |